In the last five years, the detection of inactivating mutations in SMARCA4 that cause loss of nuclear protein expression has emerged as a differential diagnostic marker between some types of sarcoma and carcinomas sharing similar molecular characteristics. The gene discussed is SMARCA4; the disease is sarcoma.